Recertify to Continue Prescribing Clozapine

Please see the FDA notice concerning Clozapine REMS program updates/deadline extensions.

A SINGLE new registry will streamline clozapine management.

We know clozapine is very effective for schizophrenia...but it's often a last resort due to neutropenia risk and its complex monitoring.

The new Clozapine REMS Program is now the ONLY registry available.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote